Safi R. Bahcall is President at SYNTA PHARMACEUTICALS CORP (SNTA). They have made 12 open-market trades across 1 company since 2007, most recently 2013-11-13.
CIK 0001325719
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
12 open-market purchases totalling $662K since 2007, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SNTA | 2,053,135 | — |
Shares reported on the most recent Form 4, priced at the 2013-11-15 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SNTA | BUY | 2013-11-13 | 2013-11-15 | $3.75 | $75K | N/A | N/A | N/A |
| SNTA | BUY | 2013-06-28 | 2013-07-01 | $5.03 | $50K | N/A | N/A | N/A |
| SNTA | BUY | 2013-06-21 | 2013-06-24 | $4.12 | $82K | N/A | N/A | N/A |
| SNTA | BUY | 2013-06-14 | 2013-06-17 | $4.06 | $41K | N/A | N/A | N/A |
| SNTA | BUY | 2013-06-06 | 2013-06-06 | $4.04 | $40K | N/A | N/A | N/A |
| SNTA | BUY | 2012-11-12 | 2012-11-13 | $7.12 | $71K | N/A | N/A | N/A |
| SNTA | BUY | 2012-06-29 | 2012-07-02 | $5.34 | $53K | N/A | N/A | N/A |
| SNTA | BUY | 2011-03-15 | 2011-03-15 | $4.45 | $22K | N/A | N/A | N/A |
| SNTA | BUY | 2010-06-10 | 2010-06-10 | $3.05 | $31K | N/A | N/A | N/A |
| SNTA | BUY | 2010-01-08 | 2010-01-12 | $4.50 | $100K | N/A | N/A | N/A |
| SNTA | BUY | 2009-08-06 | 2009-08-07 | $2.85 | $57K | N/A | N/A | N/A |
| SNTA | BUY | 2007-11-26 | 2007-11-26 | $7.83 | $39K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.